1-111230823-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001025199.2(CHI3L2):c.-86T>C variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000142 in 1,614,158 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001025199.2 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHI3L2 | NM_004000.3 | c.152T>C | p.Ile51Thr | missense_variant | Exon 3 of 11 | ENST00000369748.9 | NP_003991.2 | |
CHI3L2 | NM_001025199.2 | c.-86T>C | 5_prime_UTR_premature_start_codon_gain_variant | Exon 2 of 10 | NP_001020370.1 | |||
CHI3L2 | NM_001025197.1 | c.122T>C | p.Ile41Thr | missense_variant | Exon 2 of 10 | NP_001020368.1 | ||
CHI3L2 | NM_001025199.2 | c.-86T>C | 5_prime_UTR_variant | Exon 2 of 10 | NP_001020370.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152156Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000278 AC: 7AN: 251474Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135910
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1461884Hom.: 0 Cov.: 32 AF XY: 0.00000825 AC XY: 6AN XY: 727246
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152274Hom.: 0 Cov.: 31 AF XY: 0.0000403 AC XY: 3AN XY: 74466
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.152T>C (p.I51T) alteration is located in exon 3 (coding exon 3) of the CHI3L2 gene. This alteration results from a T to C substitution at nucleotide position 152, causing the isoleucine (I) at amino acid position 51 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at